Corcept Therapeutics | CORT - Trade Creditors


Corcept Therapeutics reported $21.92M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 16.33M 28.24M Sep/2026
Alaunos Therapeutics USD 732K 332K Jun/2026
ANI Pharmaceuticals USD 74.41M 585K Sep/2026
Ardelyx USD 33.66M 4.75M Sep/2026
Aurora Cannabis CAD 56.83M 47.52M Jun/2026
BioMarin Pharmaceutical USD 946.11M 32.44M Sep/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Canopy Growth CAD 28.61M 6.21M Jun/2026
Corcept Therapeutics USD 21.92M 7.01M Sep/2026
Eli Lilly USD 5.79B 319M Sep/2026
J&J USD 9.32B 94M Sep/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
Lexicon Pharmaceuticals USD 3M 87K Mar/2026
Merck USD 5.03B 1.2B Sep/2026
Nektar Therapeutics USD 10.03M 744K Mar/2026
Novartis USD 4.24B 15M Sep/2026
Novartis USD 4.24B 79M Sep/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.5M 4K Sep/2026
Pfizer USD 4.07B 511M Sep/2026
Supernus Pharmaceuticals USD 8.52M 2.92M Sep/2026
TG Therapeutics USD 176.86M 36.83M Sep/2026